Celldex Therapeutics Inc. (CLDX) Social Stream

Celldex Therapeutics Inc. (CLDX): $29.16

0.24 (+0.83%)

POWR Rating

Component Grades













Add CLDX to Watchlist
Sign Up

Industry: Biotech


of 395

in industry

Celldex Therapeutics Inc (CLDX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Celldex Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-14 5 $68 $60 $64.833 $34.59 87.43%
2022-03-01 6 $68 $59 $64.5 $34.59 86.47%

The Trend in the Analyst Price Target

CLDX's average price target has moved up $38.5 over the prior 13 months.

CLDX reports an average of 60.32% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 0 36 32 34.330 22.81 50.5%
2021-04-05 3 36 32 34.330 22.41 53.19%
2021-09-03 4 68 54 62.250 54.23 14.79%
2022-02-14 5 68 60 64.833 31.65 104.84%
2022-03-01 6 68 60 64.833 31.58 105.3%

CLDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations

Over the past 120 days, CLDX's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Celldex Therapeutics Inc's variance in analysts' estimates is lower than 58.82% of all US stocks.
  • Celldex Therapeutics Inc's average analyst price target is greater than 230.47% of Pharmaceutical Products stocks.
  • CLDX has a greater upside potential (average analyst target price relative to current price) than 230.12% of stocks in the mid market cap category.
  • In terms of how Celldex Therapeutics Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 100.65% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Celldex Therapeutics Inc are ZYME, ZNTL, and YMAB.

Make investment decisions regarding CLDX using the data that counts. Try POWR Ratings for free.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4982 seconds.